154 related articles for article (PubMed ID: 37819647)
1. Structural Basis for Highly Selective Class II Alpha Phosphoinositide-3-Kinase Inhibition.
Kücükdisli M; Bel-Abed H; Cirillo D; Lo WT; Efrém NL; Horatscheck A; Perepelittchenko L; Prokofeva P; Ehret TAL; Radetzki S; Neuenschwander M; Specker E; Médard G; Müller S; Wilhelm S; Kuster B; von Kries JP; Haucke V; Nazaré M
J Med Chem; 2023 Oct; 66(20):14278-14302. PubMed ID: 37819647
[TBL] [Abstract][Full Text] [Related]
2. Development of selective inhibitors of phosphatidylinositol 3-kinase C2α.
Lo WT; Belabed H; Kücükdisli M; Metag J; Roske Y; Prokofeva P; Ohashi Y; Horatscheck A; Cirillo D; Krauss M; Schmied C; Neuenschwander M; von Kries JP; Médard G; Kuster B; Perisic O; Williams RL; Daumke O; Payrastre B; Severin S; Nazaré M; Haucke V
Nat Chem Biol; 2023 Jan; 19(1):18-27. PubMed ID: 36109648
[TBL] [Abstract][Full Text] [Related]
3. Insulin-feedback via PI3K-C2alpha activated PKBalpha/Akt1 is required for glucose-stimulated insulin secretion.
Leibiger B; Moede T; Uhles S; Barker CJ; Creveaux M; Domin J; Berggren PO; Leibiger IB
FASEB J; 2010 Jun; 24(6):1824-37. PubMed ID: 20061534
[TBL] [Abstract][Full Text] [Related]
4. The class II phosphoinositide 3-kinases PI3K-C2α and PI3K-C2β differentially regulate clathrin-dependent pinocytosis in human vascular endothelial cells.
Aung KT; Yoshioka K; Aki S; Ishimaru K; Takuwa N; Takuwa Y
J Physiol Sci; 2019 Mar; 69(2):263-280. PubMed ID: 30374841
[TBL] [Abstract][Full Text] [Related]
5. Autoregulation of Class II Alpha PI3K Activity by Its Lipid-Binding PX-C2 Domain Module.
Wang H; Lo WT; Vujičić Žagar A; Gulluni F; Lehmann M; Scapozza L; Haucke V; Vadas O
Mol Cell; 2018 Jul; 71(2):343-351.e4. PubMed ID: 30029007
[TBL] [Abstract][Full Text] [Related]
6. Essential role of class II phosphatidylinositol-3-kinase-C2α in sphingosine 1-phosphate receptor-1-mediated signaling and migration in endothelial cells.
Biswas K; Yoshioka K; Asanuma K; Okamoto Y; Takuwa N; Sasaki T; Takuwa Y
J Biol Chem; 2013 Jan; 288(4):2325-39. PubMed ID: 23192342
[TBL] [Abstract][Full Text] [Related]
7. An Overview of Class II Phosphoinositide 3-Kinases.
Heng EYZ; Maffucci T
Curr Top Microbiol Immunol; 2022; 436():51-68. PubMed ID: 36243839
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Ca2+-dependent activation of phosphoinositide 3-kinase class IIα isoform-Rho axis in blood vessels of spontaneously hypertensive rats.
Seok YM; Azam MA; Okamoto Y; Sato A; Yoshioka K; Maeda M; Kim I; Takuwa Y
Hypertension; 2010 Nov; 56(5):934-41. PubMed ID: 20921425
[TBL] [Abstract][Full Text] [Related]
9. The role of phosphoinositide 3-kinase C2alpha in insulin signaling.
Falasca M; Hughes WE; Dominguez V; Sala G; Fostira F; Fang MQ; Cazzolli R; Shepherd PR; James DE; Maffucci T
J Biol Chem; 2007 Sep; 282(38):28226-36. PubMed ID: 17644513
[TBL] [Abstract][Full Text] [Related]
10. Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle.
Wang Y; Yoshioka K; Azam MA; Takuwa N; Sakurada S; Kayaba Y; Sugimoto N; Inoki I; Kimura T; Kuwaki T; Takuwa Y
Biochem J; 2006 Mar; 394(Pt 3):581-92. PubMed ID: 16336212
[TBL] [Abstract][Full Text] [Related]
11. Class II PI3Ks α and β Are Required for Rho-Dependent Uterine Smooth Muscle Contraction and Parturition in Mice.
Sarker MAK; Aki S; Yoshioka K; Kuno K; Okamoto Y; Ishimaru K; Takuwa N; Takuwa Y
Endocrinology; 2019 Jan; 160(1):235-248. PubMed ID: 30476019
[TBL] [Abstract][Full Text] [Related]
12. Insulin activates the alpha isoform of class II phosphoinositide 3-kinase.
Brown RA; Domin J; Arcaro A; Waterfield MD; Shepherd PR
J Biol Chem; 1999 May; 274(21):14529-32. PubMed ID: 10329640
[TBL] [Abstract][Full Text] [Related]
13. Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis.
Tibolla G; Piñeiro R; Chiozzotto D; Mavrommati I; Wheeler AP; Norata GD; Catapano AL; Maffucci T; Falasca M
PLoS One; 2013; 8(1):e53808. PubMed ID: 23320105
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the alpha-isoform of class II phosphoinositide 3-kinase gene expression leads to apoptotic cell death.
Kang S; Song J; Kang J; Kang H; Lee D; Lee Y; Park D
Biochem Biophys Res Commun; 2005 Apr; 329(1):6-10. PubMed ID: 15721265
[TBL] [Abstract][Full Text] [Related]
15. Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion.
Mavrommati I; Cisse O; Falasca M; Maffucci T
Sci Rep; 2016 Mar; 6():23277. PubMed ID: 26983806
[TBL] [Abstract][Full Text] [Related]
16. Class II phosphatidylinositol 3-kinase isoforms in vesicular trafficking.
Yoshioka K
Biochem Soc Trans; 2021 Apr; 49(2):893-901. PubMed ID: 33666217
[TBL] [Abstract][Full Text] [Related]
17. Are class II phosphoinositide 3-kinases potential targets for anticancer therapies?
Traer CJ; Foster FM; Abraham SM; Fry MJ
Bull Cancer; 2006 May; 93(5):E53-8. PubMed ID: 16777618
[TBL] [Abstract][Full Text] [Related]
18. Class I PI3K Biology.
Aytenfisu TY; Campbell HM; Chakrabarti M; Amzel LM; Gabelli SB
Curr Top Microbiol Immunol; 2022; 436():3-49. PubMed ID: 36243838
[TBL] [Abstract][Full Text] [Related]
19. Class II PI3K Functions in Cell Biology and Disease.
Gulluni F; De Santis MC; Margaria JP; Martini M; Hirsch E
Trends Cell Biol; 2019 Apr; 29(4):339-359. PubMed ID: 30691999
[TBL] [Abstract][Full Text] [Related]
20. Ca2+-regulated pool of phosphatidylinositol-3-phosphate produced by phosphatidylinositol 3-kinase C2alpha on neurosecretory vesicles.
Wen PJ; Osborne SL; Morrow IC; Parton RG; Domin J; Meunier FA
Mol Biol Cell; 2008 Dec; 19(12):5593-603. PubMed ID: 18843041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
